Navigation Links
Targeted therapy decreases progression rate in thyroid cancer
Date:9/17/2010

ROCHESTER, Minn. -- The drug pazopanib may help revolutionize the care of patients with metastatic, rapidly progressive differentiated thyroid cancers, say researchers at Mayo Clinic who are publishing findings of a phase II clinical trial in The Lancet Oncology.

VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Keith Bible describing the research, are available on the Mayo Clinic News Blog. Password: bible.

The researchers studied 37 patients with the most aggressive form of this cancer -- developing in less than 5 percent of patients with differentiated thyroid cancer -- and found that about half (18) patients had a long-lasting response to pazopanib. Of that group, 12 are still alive without disease progression. The median progression-free survival time was 11.7 months, with an overall survival rate of 81 percent at one year.

The researchers say that, to their knowledge, these findings represent by far the highest response rate yet reported in such aggressive cases of differentiated thyroid cancer. They caution however, that this drug is not meant to be used in slow-growing differentiated thyroid cancers and that they cannot assess the survival advantage pazopanib offers to the patients studied.

Determining survival benefit would require a randomized clinical trial testing the agent, which inhibits all three vascular endothelial growth factor (VEGF) receptors, compared to other treatments or a placebo.

"In this group of patients, we would have expected the cancer to have progressed in everyone within six mo
'/>"/>

Contact: Nicole Engler
engler.nicole@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted agent shows promise for chronic lymphoid leukemia
2. Targeted strategies needed to find, prevent and treat breast cancer among Mexican-origin women
3. In Early Trial, Targeted Therapy Fights Advanced Melanoma
4. New targeted therapy for advanced melanoma associated with 80 percent response rate
5. Targeted drug leads to regression of metastatic melanoma with mutated BRAF gene
6. NYU Langone offers vascular-targeted photodynamic therapy for localized prostate cancer
7. Radiation device allows for targeted breast radiation to control cancer
8. Surveillance colonoscopy should be targeted to high-risk patients
9. Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment
10. Experimental targeted therapy shows early promise against medulloblastomas
11. Targeted Therapy Shows Promise Against Deadly Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 2015 The IRS released an ... that, “criminals used taxpayer-specific data acquired from non-IRS sources ... tax accounts through IRS’ “Get Transcript” application. This data ... address.” , “You don’t even have to be ... it was only a matter of time, especially after ...
(Date:5/29/2015)... May 30, 2015 “In the ... local and federal regulations, we provide education that ... patients who are suffering from pain, within the ... Nalamachu, MD, professor of rehabilitation medicine and President/Medical ... Overland Park, Kansas. , A new flight of ...
(Date:5/29/2015)... Tallahassee, FL (PRWEB) May 29, 2015 Ready ... trip, it’s important for all drivers to get their vehicles ... do to be prepared. Advanced Driving Systems (ADS) is ready ... some tips on preparing for summer road trips. , When ... do the following to ensure that the trip goes smoothly ...
(Date:5/29/2015)... May 29, 2015 The science of ... Los Angeles thanks to the efforts of internationally recognized ... has combined ARTAS hair restoration and manual ... restoration procedures available anywhere. , A Follicular Unit ... individually harvesting hair follicle grafts from the donor areas ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
Breaking Medicine News(10 mins):Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3
... of the communicable diseases in the country, according to ... Health and Family Welfare//. The news report was released ... a village near Vriddachalam. Chidambaram MP, E Ponnusamy, MLAs ... function. ,As many as 60 government doctors, ...
... UNICEF would collaborate on spreading awareness regarding the transmission ... spreading awareness to young people the dangers of HIV ... as children’s and young people are more attracted towards ... Understanding was signed in Delhi in the presence of ...
... is an idiopathic inflammatory disorder of the ... remain incompletely understood, many experimental and clinical ... in its pathogenesis//. ,In genetically ... failure of normal regulatory constraints on the ...
... of Delaware have developed a unique nanobomb that can ... more specifically breast cancer cells//. ,This latest attack ... and Oncology Issues by Balaji Panchapakesan, assistant professor of ... that the nanobomb technology is still in its infancy ...
... Immunodeficiency Virus type 1 (HIV-1) infection has improved ... 1996//. More recently, new drugs have been approved, ... while some previously popular drugs are being used ... Resistance testing is used more commonly in clinical ...
... have found an active gene in the legs of fleas, ... the flea to jump and leap at incredible heights and ... an incredible speed of 200 times/second. , ,Scientists have ... cultured them in the bacteria E.coli and found that it ...
Cached Medicine News:Health News:Non-Communicable Diseases Mounting Up At An Alarming Rate in India 2Health News:Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness 2Health News:Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis 2Health News:Simplest therapeutic regimen found less effective against HIV 2Health News:Resilin Protein from Flea can be used for cardiovascular disease 2
(Date:5/29/2015)... VANCOUVER, British Columbia and ... DelMar Pharmaceuticals, Inc. (OTCQX: ... focused on developing and commercializing proven cancer therapies ... data at the American Association of Cancer ... on the potential for its lead product ...
(Date:5/29/2015)...  Eli Lilly and Company (NYSE: LLY ) ... they have entered into a clinical trial collaboration to ... anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ... medicine. The planned study will assess the combination as ... The Phase I study is expected to establish ...
(Date:5/29/2015)... 2015  World-renowned prostate surgeon and New York Urologist, Dr. ... of MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive ... Center at Lenox Hill Hospital is the only center ... New York City . We,ve seen tremendous improvement ... The use of an MRI makes for a much more ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
... UK pharma group GlaxoSmithKline reports a 2% ... underlying sales momentum. In an interview with ... CFO Simon Dingemans review Q2 results including overall delivery ... a review of the recently implemented Drug Performance Units. ...
... Pharmaceuticals, Inc. announced the following news today concerning the future ... On December 31, 2011, the FDA ban ... a propellant will become effective. Primatene® Mist has ... symptoms for over 40 years. The ban on the sale ...
Cached Medicine Technology:Statement on Availability of Primatene® Mist CFC 2
Inquire...
The Perfect Single basic Vac Manifold is used to process a single 96-well plate; processing time is approximately 30 minutes....
The Perfect Vac Quad Manifold allows one to four 96-well plates to be processed simultaneously. A single plate may be processed in 30 minutes; four plates are processed in 45 minutes....
... from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten ... today. ... ... ...
Medicine Products: